OGB

Old Glory Bank Launches Merchandise Store to Serve Freedom-Loving Americans

Retrieved on: 
Thursday, February 29, 2024
Banking, Professional Services, Finance, Friends, OGB, Pet, Tumbler, Coffee

Old Glory Bank, the pro-American online community bank, announced today the official launch of its “Old Glory Bank Merchandise Store,” offering only made-in-America products.

Key Points: 
  • Old Glory Bank, the pro-American online community bank, announced today the official launch of its “Old Glory Bank Merchandise Store,” offering only made-in-America products.
  • “What a tremendous year we’ve had serving Middle America,” said Old Glory Bank Chief Strategy Officer Eric Ohlhausen.
  • “It wouldn’t be an Old Glory Bank merchandise store without Old Glory herself,” Ohlhausen said.
  • Customers who use Old Glory Pay, the proprietary app exclusive to Old Glory Bank, will receive 10% off all purchases through March 31, 2024.

Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic Collaboration with Weizmann Institute of Science

Retrieved on: 
Wednesday, January 31, 2024
Partnership, Weizmann Institute of Science, Science, Research, Orange, Government, Therapy, Mentorship, Patient, University, Faculty, Biotechnology, Drug discovery, Chemistry, Investment, Biochemistry, Drug development, Biology, AUC, Student, OGB, Technology transfer, Pharmaceutical industry

Orange Grove’s agreement with the Weizmann Institute of Science includes a formal memorandum of understanding with its academic innovation hub, known as Bina (Bridge, Innovate, Nurture, Advance).

Key Points: 
  • Orange Grove’s agreement with the Weizmann Institute of Science includes a formal memorandum of understanding with its academic innovation hub, known as Bina (Bridge, Innovate, Nurture, Advance).
  • Through its collaboration with Bina, Orange Grove will guide and mentor cutting-edge early-stage research taking place across the Weizmann Institute of Science.
  • As part of the collaboration, Orange Grove Bio and Bina will scout for translation of scientific discoveries made by researchers across the Weizmann Institute of Science.
  • Orange Grove Bio fosters strong relationships with technology transfer offices outside of the traditional medical technology hubs of Boston and San Francisco.

Orange Grove Bio Subsidiary Awarded $2.05 Million SBIR Phase II Grant to Advance Development of Novel Platelet Preservation Technology

Retrieved on: 
Thursday, September 28, 2023
Heart, Maintenance, Drug development, University, Therapy, AUC, Regeneron Pharmaceuticals, PNC Center, Harvard University, SBIR, Biotechnology, University of California, San Francisco, National Heart, Lung, and Blood Institute, Pathology, OGB, Refrigeration, Head, American Academy, Research, Temperature, Lung, PNC, Autoimmunity, Bangladesh Technical Education Board, Eli Lilly, National academy, Publishing, National Academy of Medicine, Lilly, Patient, UCSF, Risk, Immune system, Small Business Innovation Research, G04, Drug discovery, Science, Transforming protein RhoA, Immunology, Health, NIH, Technology transfer, Allen Institute, Pharmaceutical industry, Vaccine, MBBS

Preservation Bio seeks to transform blood banking for donated platelets with an ex vivo additive that protects platelets from the damage normally caused by refrigeration.

Key Points: 
  • Preservation Bio seeks to transform blood banking for donated platelets with an ex vivo additive that protects platelets from the damage normally caused by refrigeration.
  • The SBIR grant will help fund Preservation Bio’s continued advancement of G04 through preclinical development and toward the clinic.
  • With more than eight million platelet units donated yearly, the global platelet market is estimated to be at least $4 billion.
  • Orange Grove Bio fosters strong relationships with technology transfer offices outside of the traditional medical technology hubs of Boston and San Francisco.

THE GUINNESS OPEN GATE BREWERY TO OPEN CHICAGO TAPROOM IN SUMMER 2023, BRINGING LOCALLY-INSPIRED GUINNESS BREWS TO THE WEST LOOP

Retrieved on: 
Friday, March 10, 2023
Guinness, Partnership, Beer, Intelligentsia, Life, Open Water, News, Windy City, Biophysical environment, Guinness Foreign Extra Stout, Carbon, Social media, OGB, LEED, Diageo

CHICAGO, March 10, 2023 /PRNewswire/ -- Guinness today announced that the Guinness Open Gate Brewery (OGB) Chicago will open its doors to the public this coming summer, bringing locally-inspired brews and community collaborations to Chicago's vibrant West Loop neighborhood. This is Guinness' second brewing facility and taproom in the United States, the first of which is the Guinness Open Gate Brewery in Baltimore, Md.

Key Points: 
  • OGB Chicago Marks Guinness' Second U.S. Taproom, Will Blend the Rich History of Guinness With Chicago Flair While Driving Community Partnerships
    CHICAGO, March 10, 2023 /PRNewswire/ -- Guinness today announced that the Guinness Open Gate Brewery (OGB) Chicago will open its doors to the public this coming summer, bringing locally-inspired brews and community collaborations to Chicago's vibrant West Loop neighborhood.
  • This is Guinness' second brewing facility and taproom in the United States, the first of which is the Guinness Open Gate Brewery in Baltimore, Md.
  • Guinness Open Gate Brewery to open Chicago Taproom in Summer 2023.
  • Located in Chicago's West Loop neighborhood at 901 W. Kinzie St., the Guinness Open Gate Brewery Chicago will deliver an American craft beer experience that is authentically Guinness and distinctly local.

Operation Good Boy, a Veteran-founded Pet Products & Lifestyle Company, Launches on Veterans Day with a Mission to Celebrate the Unconditional Loyalty that Exists in Both Military Service Members and in Dogs.

Retrieved on: 
Friday, November 11, 2022
Other Retail, Online Retail, Specialty, Women, Pets, Men, Veterans, Retail, Family, Defense, Consumer, Dog, Health, Animal, Tres, Combat engineer, 1st Cavalry, Veteran, Rehabilitation, Intention, Army, Veterinarian, ONE, OGB, Toy

Operation Good Boy Company (Operation Good Boy," OGB or the Company), a new purpose-driven pet company founded to celebrate Veterans, active-duty military, pet enthusiasts and their dogs, launches today on Veterans Day, November 11, 2022.

Key Points: 
  • Operation Good Boy Company (Operation Good Boy," OGB or the Company), a new purpose-driven pet company founded to celebrate Veterans, active-duty military, pet enthusiasts and their dogs, launches today on Veterans Day, November 11, 2022.
  • Tom created the business with the intention of acknowledging the ultimate sacrifice of military service and celebrating the unconditional loyalty of dogs.
  • The Operation Good Boy company celebrates those who have served and aims to be inclusive of veterans at all phases of the business.
  • These animals embody the same sense of loyalty of service members and in fact, are veterans themselves.

Magnuson Center for Entrepreneurship at Dartmouth College and Orange Grove Bio Establish Collaboration to Strengthen Biotech Ecosystem and Support Development and Commercialization of Novel Therapeutics

Retrieved on: 
Thursday, November 10, 2022
GLOBE, University, DIAC, The Center, Faculty, Partnership, Communication, OGB, Education, Research, Center, Academic health science centre, Dartmouth College, Immunology, Technology transfer, EIR, Entrepreneurship, Drug development, Biotechnology, Patient, Therapy, Student, Hotbed, Industry, Pharmaceutical industry, Management, Cancer

The collaboration will include a Dartmouth Ph.D. internship program led by Orange Grove Bio, as well as members of the Orange Grove Bio team serving as an Entrepreneur in Residence at the Magnuson Center and advisors to the Dartmouth Innovations Accelerator for Cancer (DIAC).

Key Points: 
  • The collaboration will include a Dartmouth Ph.D. internship program led by Orange Grove Bio, as well as members of the Orange Grove Bio team serving as an Entrepreneur in Residence at the Magnuson Center and advisors to the Dartmouth Innovations Accelerator for Cancer (DIAC).
  • We are committed to fostering and supporting this rich scientific ecosystem through collaboration with the Magnuson Center, academic researchers, and investors to drive the commercialization of novel therapies for patients.
  • The Magnuson Center for Entrepreneurship provides hands-on education and experiences to Dartmouth students, faculty, and alumni entrepreneurs.
  • Orange Grove Bio (OGB) is a capital allocation and asset development biotech company.

Cincinnati Children’s Hospital Medical Center and Orange Grove Bio Establish Collaboration to Develop and Commercialize Novel Therapeutics

Retrieved on: 
Wednesday, March 9, 2022
University, Faculty, B cell, National, Laboratory, Orange, Cincinnati Children's Hospital Medical Center, Entrepreneurship, Drug development, Partnership, Research, Therapy, Hospital, Respiratory distress syndrome, Academic health science centre, Education, Autoimmunity, Cancer, OGB, Lists of diseases, Health, Child, Inflammation, Technology transfer, GLOBE, News, Patient, CID, Â, Disease, Sabin, Bypass (road), Cincinnati metropolitan area, Biotechnology, U.S. News & World Report, Pharmaceutical industry

CINCINNATI, March 09, 2022 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and Cincinnati Childrens Hospital Medical Center today announced the establishment of a collaboration designed to advance the development and commercialization of novel therapeutics by supporting the translation of scientific discoveries made by researchers at Cincinnati Childrens.

Key Points: 
  • CINCINNATI, March 09, 2022 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and Cincinnati Childrens Hospital Medical Center today announced the establishment of a collaboration designed to advance the development and commercialization of novel therapeutics by supporting the translation of scientific discoveries made by researchers at Cincinnati Childrens.
  • Under terms of the collaboration, Orange Grove Bio will provide commercialization guidance and support to Cincinnati Childrens Innovation Ventures.
  • Orange Grove Bio fosters strong relationships with technology transfer offices outside of the traditional medical technology hubs of Boston and San Francisco.
  • Additional information about technologies developed at Cincinnati Childrens may be found at Innovation.CincinnatiChildrens.org
    Orange Grove Bio (OGB) is an emerging, preclinical, capital allocation and asset development biotech company.

SV Investment and Orange Grove Bio Establish Partnership to Jointly Source and Develop Novel Therapeutics in the U.S. and Korea

Retrieved on: 
Tuesday, February 8, 2022
GLOBE, Technology transfer, Philosophy, Research, Lists of diseases, Cancer, International Growth Centre, Investment, Technology, Patient, SV, OGB, University, Therapy, Drug development, Partnership, Pharmaceutical industry, Drug, Renewable energy

CINCINNATI, Ohio and SEOUL, Korea, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Orange Grove Bio, a U.S.-based preclinical drug investment and development firm, and SV Investment, a Korea-based venture capital and private equity firm, today announced the establishment of a new partnership through which the companies will collaborate on jointly sourcing and developing novel therapeutics in the United States and Korea. As priority partners, the companies will cultivate the U.S. and Korean biotech landscape through technology licensing and company creation in their respective geographic areas.

Key Points: 
  • As appropriate, Orange Grove will work to license these technologies as a basis for life science company creation in the U.S., with SV Investment serving as an early-stage investor in the companies.
  • Additionally, Orange Grove will identify appropriate drug development licensing opportunities at U.S.-based academic institutions that SV Investment may pursue for development and company creation in Korea.
  • We are eager to enter this international partnership with the team at Orange Grove Bio, as it will enable SV Investment to rapidly grow its footprint in the United States, said Won-Ho Hong, chief executive officer of SV Investment.
  • SVs investment philosophy is to discover and develop promising companies and establish robust investment networks between startups in Korea and internationally.

The University of Colorado Anschutz Medical Campus and Orange Grove Bio to Collaborate on Development and Commercialization of Novel Therapies

Retrieved on: 
Wednesday, December 8, 2021
Aurora, Children's Hospital Colorado, OGB, Medicine, Entrepreneurship, Research, University, Laboratory, Health, GLOBE, Therapy, Growth, Lists of diseases, Drug development, University of Colorado Hospital, Faculty, Patient, Technology transfer, Cancer, Partnership, Inflammation, University of Colorado Denver, Doctor of Philosophy, CU, Education, Autoimmunity, Adult, Student, Toxicology, Pharmaceutical industry

As part of this effort, Orange Grove and CU Anschutz will support educational programming and entrepreneurial initiatives for CU Anschutz researchers, including faculty and students.

Key Points: 
  • As part of this effort, Orange Grove and CU Anschutz will support educational programming and entrepreneurial initiatives for CU Anschutz researchers, including faculty and students.
  • "Our collaboration with Orange Grove Bio will support further development of promising technologies from academia, with the goal of bringing significant life-changing therapies to patients."
  • Orange Grove Bio fosters strong relationships with technology transfer offices outside of the traditional medical technology hubs of Boston and San Francisco.
  • The University of Colorado Anschutz Medical Campusis a world-class medical destination at the forefront of transformative science, medicine, educationand patient care.

The University of Pittsburgh and Orange Grove Bio Establish Partnership to Develop and Commercialize Novel Therapeutics

Retrieved on: 
Wednesday, November 17, 2021
University, Cancer, Associate, Student, Health, Education, Technology transfer, Entrepreneurship, UPMC, Research, Partnership, GLOBE, Innovation and Entrepreneurship Group, Faculty, Therapy, OGB, Inflammation, Innovation, Hotbed, Autoimmunity, Patient, Lists of diseases, NIH, Drug development, University of Pittsburgh, Pitt, Pharmaceutical industry, Management

Under terms of the partnership, Orange Grove Bio will provide commercialization guidance and support to the University of Pittsburgh Innovation Institute, an internship program for the universitys Ph.D. students, and educational seminars for primary investigators and researchers at the university.

Key Points: 
  • Under terms of the partnership, Orange Grove Bio will provide commercialization guidance and support to the University of Pittsburgh Innovation Institute, an internship program for the universitys Ph.D. students, and educational seminars for primary investigators and researchers at the university.
  • Additionally, as part of these activities, Orange Grove Bios head of chemistry, William H. Miller, Ph.D., has joined the University of Pittsburghs external advisory board for novel technologies.
  • Orange Grove Bios mission is to develop new therapeutic options for patients by harnessing the significant research potential found in universities across the United States.
  • Orange Grove Bio fosters strong relationships with technology transfer offices outside of the traditional medical technology hubs of Boston and San Francisco.